377 related articles for article (PubMed ID: 25182711)
21. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin.
Hamer DH
Am J Respir Crit Care Med; 2000 Jul; 162(1):328-30. PubMed ID: 10903263
[TBL] [Abstract][Full Text] [Related]
22. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM; Sawyer AM; Kollef MH
Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
[TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
Mastoraki A; Douka E; Kriaras I; Stravopodis G; Manoli H; Geroulanos S
Surg Infect (Larchmt); 2008 Apr; 9(2):153-60. PubMed ID: 18426347
[TBL] [Abstract][Full Text] [Related]
24. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
[TBL] [Abstract][Full Text] [Related]
25. Colistin: an update on the antibiotic of the 21st century.
Biswas S; Brunel JM; Dubus JC; Reynaud-Gaubert M; Rolain JM
Expert Rev Anti Infect Ther; 2012 Aug; 10(8):917-34. PubMed ID: 23030331
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin.
Schina M; Spyridi E; Daoudakis M; Mertzanos E; Korfias S
Int J Infect Dis; 2006 Mar; 10(2):178-9. PubMed ID: 16263315
[No Abstract] [Full Text] [Related]
27. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections.
Tascini C; Gemignani G; Ferranti S; Tagliaferri E; Leonildi A; Lucarini A; Menichetti F
J Chemother; 2004 Jun; 16(3):282-7. PubMed ID: 15330326
[TBL] [Abstract][Full Text] [Related]
28. Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.
Sorlí L; Luque S; Segura C; Campillo N; Montero M; Esteve E; Herrera S; Benito N; Alvarez-Lerma F; Grau S; Horcajada JP
BMC Infect Dis; 2017 Jan; 17(1):11. PubMed ID: 28056821
[TBL] [Abstract][Full Text] [Related]
29. In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
Bozkurt-Guzel C; Savage PB; Gerceker AA
Chemotherapy; 2011; 57(6):505-10. PubMed ID: 22286090
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
[TBL] [Abstract][Full Text] [Related]
31. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis.
Griese M; Müller I; Reinhardt D
Eur J Med Res; 2002 Feb; 7(2):79-80. PubMed ID: 11891148
[TBL] [Abstract][Full Text] [Related]
32. A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.
Littlewood KJ; Higashi K; Jansen JP; Capkun-Niggli G; Balp MM; Doering G; Tiddens HA; Angyalosi G
J Cyst Fibros; 2012 Sep; 11(5):419-26. PubMed ID: 22717535
[TBL] [Abstract][Full Text] [Related]
33. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa.
Yamagishi Y; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Nakai H; Mikamo H
Chemotherapy; 2017; 62(2):105-110. PubMed ID: 27788502
[TBL] [Abstract][Full Text] [Related]
36. Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician.
Martis N; Leroy S; Blanc V
J Infect; 2014 Jul; 69(1):1-12. PubMed ID: 24631777
[TBL] [Abstract][Full Text] [Related]
37. Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
Kim J; Kang CI; Baek JY; Cho SY; Kim SH; Ko KS; Chung DR; Peck KR; Song JH
Int J Antimicrob Agents; 2014 Apr; 43(4):391-3. PubMed ID: 24637223
[No Abstract] [Full Text] [Related]
38. Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia.
Linden PK; Paterson DL
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S89-94. PubMed ID: 16894521
[TBL] [Abstract][Full Text] [Related]
39. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.
Cunha MT; Murça MA; Nigro S; Klautau GB; Salles MJC
BMC Infect Dis; 2018 Apr; 18(1):157. PubMed ID: 29614973
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of colistin in a 8-year-old child with acute bone infection.
Magréault S; Petyt C; Senneville E; Fron D; Nectoux E; Loiez C; Marchand S; Grégoire N; Couet W
Clin Microbiol Infect; 2018 Sep; 24(9):1025-1026. PubMed ID: 29723571
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
